SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-056441
Filing Date
2021-11-03
Accepted
2021-11-03 16:10:59
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_inmunebioinc.htm   iXBRL 10-Q 642624
2 CERTIFICATION f10q0921ex31-1_inmunebioinc.htm EX-31.1 9382
3 CERTIFICATION f10q0921ex31-2_inmunebioinc.htm EX-31.2 9413
4 CERTIFICATION f10q0921ex32-1_inmunebioinc.htm EX-32.1 4142
5 CERTIFICATION f10q0921ex32-2_inmunebioinc.htm EX-32.2 4231
  Complete submission text file 0001213900-21-056441.txt   4069593

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20210930.xsd EX-101.SCH 54463
7 XBRL CALCULATION FILE inmb-20210930_cal.xml EX-101.CAL 33662
8 XBRL DEFINITION FILE inmb-20210930_def.xml EX-101.DEF 231631
9 XBRL LABEL FILE inmb-20210930_lab.xml EX-101.LAB 466398
10 XBRL PRESENTATION FILE inmb-20210930_pre.xml EX-101.PRE 237153
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_inmunebioinc_htm.xml XML 372759
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 211375454
SIC: 2836 Biological Products, (No Diagnostic Substances)